Multi-vial research order savings: Buy 3 vials and save 10%. Buy 5 vials and save 15%. Research Peptides only. 🎁 EVERY RETAIL ORDER INCLUDES 1 FREE VIAL 🎁 Free shipping on retail orders $350+. Bulk Pre-Orders excluded.
A practical guide to Australian Peptide’s 10-pack bulk pre-order range, including laboratory ordering considerations, batch documentation, COA access, fulfilment and the difference between bulk and standard retail orders.
A practical guide to Australian Peptide’s 10-pack bulk pre-order range, including laboratory ordering considerations, batch documentation, COA access, fulfilment and the difference between bulk and standard retail orders.
A laboratory-focused guide to peptide reconstitution, bacteriostatic water vs sterile water, peptide solubility, mg/mL concentration and why there is no universal water-to-mg ratio.
A laboratory-focused guide to peptide reconstitution, bacteriostatic water vs sterile water, peptide solubility, mg/mL concentration and why there is no universal water-to-mg ratio.
What does 10mg, 20mg, 30mg or 50mg actually mean on a peptide vial? This guide explains vial mass, purity, concentration, mcg conversion and COA interpretation using common research peptides as...
What does 10mg, 20mg, 30mg or 50mg actually mean on a peptide vial? This guide explains vial mass, purity, concentration, mcg conversion and COA interpretation using common research peptides as...
A laboratory-focused guide to understanding 10mg, 20mg, 30mg and 50mg peptide vial labels, mg/mL concentration, mcg conversions, U-100 syringe volume markings and why no universal reconstitution volume applies to every...
A laboratory-focused guide to understanding 10mg, 20mg, 30mg and 50mg peptide vial labels, mg/mL concentration, mcg conversions, U-100 syringe volume markings and why no universal reconstitution volume applies to every...
An August 2026 scientific update on investigational retatrutide (LY3437943), covering the peer-reviewed Phase 2 foundation, 2026 TRIUMPH-1, TRIUMPH-2 and TRIUMPH-3 Phase 3 topline results, evidence limitations, regulatory status and what...
An August 2026 scientific update on investigational retatrutide (LY3437943), covering the peer-reviewed Phase 2 foundation, 2026 TRIUMPH-1, TRIUMPH-2 and TRIUMPH-3 Phase 3 topline results, evidence limitations, regulatory status and what...
A pathway-level guide explaining the difference between GHRH analogues such as CJC-1295 No DAC and tesamorelin, and growth-hormone secretagogues such as ipamorelin, including receptor biology, pulsatile GH regulation, evidence quality...
A pathway-level guide explaining the difference between GHRH analogues such as CJC-1295 No DAC and tesamorelin, and growth-hormone secretagogues such as ipamorelin, including receptor biology, pulsatile GH regulation, evidence quality...
Choosing a selection results in a full page refresh.